Osteoarthritis is a leading cause of pain and disability across the world. With the population getting older and the increasing desire for individual freedom at older ages, new therapeutic approaches are urgently needed. 

Current therapies are mainly targeting the symptoms, however, none are able to structurally modify the processes of OA or prevent the disease's progression. Stem cell therapies have yielded impressive results in regenerating damaged tissues, and partly reverting the underlying aging and immunologically-related processes of osteoarthritis. 

With the next generation of stem cell-based therapies, the BeNatural-R3 StemCell International Clinic, in combination with conventional therapeutic measures, offer a novel regenerative approach to treating Osteoarthritis. 

Recent evidence-based scientific research has shown that stem cell-based therapies are able to effectively modulate the immune responses of OA, regenerate lost nerve supply, differentiate into chondrocytes (the cells that produce cartilage), etc., and offerlong lasting effects for treating OA, as compared to standard medications (like nonsteroidal anti-inflammatory drugs such as 'NSAIDs') which only temporarily mask the symptoms. 

 

Osteoarthritis is mainly considered a cause of aging, where aging itself is a complicated process which is not entirely understood. Younger people sometimes get early osteoarthritis, primarily in the form of joint injuries or excessive strain.

 

 

Risk factors are:

 

• Joint injury

• Joints that are deformed

• Genetic defects related to joint cartilage

• Stress on the joints from certain jobs or sports

• Being overweight

• Getting older